LONDON/NEW YORK (Reuters) - Sanofi SA is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion, according to people familiar with the matter, yet another example of drugmakers trying to shed non-core assets and focus on high-growth areas. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/DxR7mcL7vBQ/story01.htm
Read More
No comments:
Post a Comment